While clinical trials offer numerous benefits, patient enrollment frequently proves challenging. It's noteworthy that a staggering 80% of clinical trials fall short of meeting their enrollment deadlines, with up to 50% of research sites enrolling just one or no patients.
Although patient recruitment for clinical trials has long been a complex task, the integration of modern technology and evolving public perceptions of the healthcare sector have added new layers of complexity to the process. Outside of technology, there are other obstacles as well that hinder biopharmaceutical companies from effectively recruiting clinical trial participants. While these challenges are genuine, they remain conquerable.
In this blog, the author sheds light on the top three common barriers to clinical trial enrollment and offers a fundamental framework for overcoming these challenges.